1. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation
by Hulya Ozsahin, Marina Cavazzana-Calvo, Luigi D. Notarangelo, Ansgar Schulz, Adrian J. Thrasher, Evelina Mazzolari, Mary A. Slatter, Francoise Le Deist, Stephane Blanche, Paul Veys, Anders Fasth, Robbert Bredius, Petr Sedlacek, Nico Wulffraat, Juan Ortega, Carsten Heilmann, Anne O'Meara, Jacek Wachowiak, Krzysztof Kalwak, Susanne Matthes-Martin, Tayfun Gungor, Aydan Ikinciogullari, Paul Landais, Andrew J. Cant, Wilhelm Friedrich, and Alain Fischer
Blood
Volume 111(1):
January 1, 2008
©2008 by American Society of Hematology

2. Event-free survival in transplanted Wiskott-Aldrich syndrome patients according to donor group (P = .01). — indicates the MSD group; …, URD group; and • •, MMRD group.
Event-free survival in transplanted Wiskott-Aldrich syndrome patients according to donor group (P = .01). — indicates the MSD group; …, URD group; and • •, MMRD group.
Hulya Ozsahin et al. Blood 2008;111:
©2008 by American Society of Hematology